Cancer Genetics and Genomics for Personalized Medicine

Personalized Medicine for Cancer: Introduction and Overview of the Book
Il-Jin Kim and David Jablons

Personalized Medicine in Lung Cancer
Daniela Morales-Espinosa, Silvia García-Román, and Rafael Rosell

Genome-Based Personalized Medicine in Liver Cancer
Jae-Jun Shim and Ju-Seog Lee

Applications of Circulating DNA Analysis in Personalized Medicine
Dana W. Y. Tsui and Muhammed Murtaza

Circulating Tumor Cells and Personalized Medicine
Jin Sun Lee, Mark Jesus M. Magbanua, Marc R. Jabon, and John W. Park

Mouse Models in Personalized Cancer Medicine
M. E. Beaulieu, T. Jauset, D. Massό-Vallés, L. Soucek, and J. R. Whitfield

Tumor Microenvironment, Therapeutic Resistance, and Personalized Medicine
Yu Sun

Personalized Immune Therapy
Joost Hegmans, Lysanne Lievense, and Joachim Aerts

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Malignancies
G. E. Bates, P. Kim, C. M. DeRosa, L. Petrukhin, Y. Bressler, and R. N. Taub

Personalized Medicine in Hereditary Cancer Syndromes
Rishi Agarwal and Vivek Subbiah

Pathology in the Era of Personalized Medicine
Hye Seung Lee

MicroRNAs in Human Cancers
Tae Jin Lee and Carlo M. Croce

Pharmacogenomics of Tamoxifen
Hitoshi Zembutsu

Biography

Il-Jin Kim is principal investigator and director of Applied Genomics in the UCSF Thoracic Oncology Program. His work focuses on the identification of novel therapeutic targets and diagnostic markers for various types of human cancers. Dr. Kim investigates human cancers using state-of-the-art technologies, including next-generation sequencing (NGS) and system genetic tools that he developed with his team. He has developed several innovative microarrays and pioneered new methods of high-throughput mutation screening, for which he holds numerous patents. He has published more than 70 papers, including in Science and Nature Communications. He has also received three awards from the American Association for Cancer Research for developing innovative genetic and diagnostic assays.

"Likely as the recent Cancer Moonshot Initiative highlights, this book well describes the importance of genetics/genomics-based personalized therapies to improve cancer treatments. This field is growing rapidly, and it is certain that many scientists should obtain professional knowledge of ‘cancer precision medicine’ to cure more cancer patients."
—Prof. Yusuke Nakamura, University of Chicago, USA

"At a time when an explosive increase in data has combined with rapidly evolving treatment paradigms, it has become particularly challenging for modern clinicians and medical researchers alike to put these advances in knowledge and practice into a proper context. It is in light of this predicament that this new volume edited by Dr. Il-Jin Kim provides a much-needed organization and harmonic understanding to the cacophony of information regarding the elusive realm of precision medicine. Covering an exhaustive array of topics ranging from the basic science of tumor modeling to the biology of tumor microenvironments to the horizon of cancer immunotherapy and advances for specific cancer types, this clearly written and very readable compilation provides a solid foundation for comprehending the rapidly advancing dawn of a truly new, personalized, precision approach to the treatment and, hopefully, the cure of cancer."
—Prof. Michael J. Mann, University of California, San Francisco